Antonio Rossi Selected Research

Antonio Rossi Research Topics

Disease

118	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2003
60	Neoplasms (Cancer) 02/2024 - 07/2004
29	Lung Neoplasms (Lung Cancer) 11/2023 - 03/2003
19	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 06/2002
14	Osteogenesis Imperfecta (Lobstein Disease) 10/2023 - 06/2007
12	Infections 12/2023 - 12/2006
12	Diastrophic dysplasia 10/2023 - 07/2003
11	Disease Progression 05/2022 - 06/2007
10	Neoplasm Metastasis (Metastasis) 02/2024 - 03/2003
9	Type 2 Diabetes Mellitus (MODY) 12/2023 - 08/2016
8	COVID-19 04/2022 - 12/2020
8	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 01/2002
7	Vomiting 01/2019 - 01/2002
7	Prolidase Deficiency 03/2015 - 09/2003
5	Mycoses (Diseases, Fungus) 01/2024 - 11/2008
5	Nausea 01/2019 - 01/2002
4	Adenocarcinoma of Lung 02/2024 - 05/2005
4	Desbuquois syndrome 08/2021 - 10/2010
4	Adenocarcinoma 02/2017 - 05/2010
4	Carcinogenesis 01/2013 - 09/2003
4	Breast Neoplasms (Breast Cancer) 12/2008 - 03/2003
3	Starvation 12/2023 - 04/2007
3	Body Weight (Weight, Body) 12/2023 - 01/2021
3	Hypoglycemia (Reactive Hypoglycemia) 12/2023 - 07/2020
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 01/2022
3	Congenital Abnormalities (Deformity) 01/2017 - 07/2010
3	Diarrhea 08/2013 - 01/2002
3	Omani type Spondyloepiphyseal dysplasia 08/2012 - 06/2008
3	Neutropenia 10/2009 - 01/2002
2	Tinea (Ringworm) 05/2024 - 01/2015
2	Root Resorption 02/2024 - 01/2023
2	Albuminuria 12/2023 - 01/2022
2	Heart Failure 12/2023 - 01/2022
2	Carcinoid Tumor (Carcinoid) 09/2023 - 05/2019

Drug/Important Bio-Agent (IBA)

28	ErbB Receptors (EGF Receptor)IBA 11/2023 - 05/2004
18	Tyrosine Kinase InhibitorsIBA 11/2023 - 05/2004
18	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2017 - 01/2007
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2004
15	PlatinumIBA 01/2017 - 11/2005
13	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2003
12	Monoclonal AntibodiesIBA 02/2024 - 01/2004
10	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 05/2016
10	Bevacizumab (Avastin)FDA Link 01/2020 - 10/2007
10	Gefitinib (Iressa)FDA Link 12/2017 - 05/2004
9	CollagenIBA 10/2023 - 06/2006
8	Biomarkers (Surrogate Marker)IBA 10/2023 - 09/2011
8	Sulfates (Sulfates, Inorganic)IBA 10/2023 - 07/2003
8	Collagen Type I (Type I Collagen)IBA 01/2023 - 07/2009
8	EnzymesIBA 01/2020 - 08/2007
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 10/2007
8	Cetuximab (Erbitux)FDA Link 06/2018 - 08/2006
8	Pemetrexed (MTA)FDA Link 01/2017 - 03/2007
8	Gemcitabine FDA Link 03/2014 - 03/2007
7	Immune Checkpoint InhibitorsIBA 02/2024 - 12/2014
7	Sulfate TransportersIBA 01/2023 - 07/2003
7	proline dipeptidase (prolidase)IBA 03/2015 - 06/2005
6	pembrolizumabIBA 02/2024 - 01/2016
6	Anaplastic Lymphoma KinaseIBA 10/2022 - 03/2013
5	GlycosaminoglycansIBA 10/2023 - 01/2017
5	CytokinesIBA 01/2023 - 05/2007
5	VaccinesIBA 04/2022 - 09/2009
5	Fluorouracil (Carac)FDA LinkGeneric 05/2003 - 01/2002
4	Keratins (Keratin)IBA 12/2023 - 07/2009
4	osimertinibIBA 11/2023 - 12/2017
4	ChloridesIBA 10/2023 - 07/2003
4	LigandsIBA 12/2022 - 12/2014
4	Proteasome InhibitorsIBA 02/2021 - 05/2014
3	Carboplatin (JM8)FDA LinkGeneric 02/2024 - 06/2002
3	CarbonIBA 12/2023 - 02/2010
3	dapagliflozinIBA 12/2023 - 01/2021
3	AntiportersIBA 10/2023 - 07/2003
3	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 01/2015
3	Proteoglycans (Proteoglycan)IBA 10/2022 - 07/2010
3	Insulin (Novolin)FDA Link 07/2022 - 12/2020
3	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 06/2005
3	Bortezomib (Velcade)FDA Link 02/2021 - 05/2014
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 10/2015
3	Liraglutide FDA Link 01/2021 - 08/2016
3	Angiogenesis InhibitorsIBA 01/2019 - 10/2007
3	SulfotransferasesIBA 01/2019 - 10/2010
3	AfatinibIBA 12/2017 - 08/2013
3	Docetaxel (Taxotere)FDA Link 04/2017 - 01/2011
3	Phosphotransferases (Kinase)IBA 01/2013 - 02/2007
3	Phosphates (Orthophosphate)IBA 10/2008 - 04/2007
3	Vinorelbine (Navelbine)FDA LinkGeneric 03/2003 - 06/2002
3	Leucovorin (Folinic Acid)FDA Link 03/2003 - 01/2002
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2024 - 04/2008
2	Programmed Cell Death 1 ReceptorIBA 02/2024 - 12/2014
2	semaglutideIBA 12/2023 - 01/2021
2	CreatinineIBA 12/2023 - 01/2022
2	Immunoconjugates (Immunoconjugate)IBA 11/2023 - 04/2023
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 07/2023 - 08/2006
2	CationsIBA 01/2023 - 05/2014

Therapy/Procedure

59	Therapeutics 02/2024 - 09/2003
58	Drug Therapy (Chemotherapy) 05/2024 - 01/2003
18	Immunotherapy 02/2024 - 12/2014
5	Radiotherapy 12/2021 - 05/2005
4	Adjuvant Chemotherapy 07/2011 - 01/2007
2	Neoadjuvant Therapy 02/2024 - 07/2021
2	Glycemic Control 12/2023 - 01/2022